Bank of New York Mellon Corp trimmed its position in Xylem Inc. (NYSE:XYL – Free Report) by 6.2% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,383,221 shares of the industrial products company’s stock after selling 91,436 shares during the quarter. Bank of New York Mellon Corp owned 0.57% of Xylem worth $178,934,000 as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds also recently made changes to their positions in the company. Maseco LLP purchased a new position in shares of Xylem in the second quarter worth $31,000. ST Germain D J Co. Inc. increased its position in Xylem by 950.0% during the 2nd quarter. ST Germain D J Co. Inc. now owns 252 shares of the industrial products company’s stock valued at $33,000 after purchasing an additional 228 shares during the period. Signature Resources Capital Management LLC purchased a new position in Xylem during the 2nd quarter valued at $39,000. Headlands Technologies LLC increased its position in Xylem by 90.6% during the 1st quarter. Headlands Technologies LLC now owns 305 shares of the industrial products company’s stock valued at $36,000 after purchasing an additional 145 shares during the period. Finally, Zions Bancorporation National Association UT purchased a new position in Xylem during the 1st quarter valued at $40,000. 87.96% of the stock is owned by hedge funds and other institutional investors.
Insider Buying and Selling at Xylem
In other news, CAO Geri-Michelle Mcshane sold 1,000 shares of the stock in a transaction that occurred on Friday, September 5th. The shares were sold at an average price of $139.96, for a total value of $139,960.00. Following the transaction, the chief accounting officer owned 2,957 shares in the company, valued at $413,861.72. This represents a 25.27% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Victoria D. Harker sold 1,700 shares of the stock in a transaction that occurred on Tuesday, November 4th. The stock was sold at an average price of $148.14, for a total transaction of $251,838.00. Following the completion of the transaction, the director owned 16,875 shares in the company, valued at $2,499,862.50. This trade represents a 9.15% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders have sold 13,121 shares of company stock worth $1,982,459. Company insiders own 0.27% of the company’s stock.
Xylem Stock Performance
Xylem (NYSE:XYL – Get Free Report) last issued its earnings results on Tuesday, October 28th. The industrial products company reported $1.37 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.23 by $0.14. The firm had revenue of $2.27 billion for the quarter, compared to the consensus estimate of $2.22 billion. Xylem had a net margin of 10.66% and a return on equity of 10.77%. The business’s revenue was up 7.8% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.11 earnings per share. Xylem has set its FY 2025 guidance at 5.030-5.080 EPS. Sell-side analysts anticipate that Xylem Inc. will post 4.65 EPS for the current fiscal year.
Xylem Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Thursday, September 25th. Shareholders of record on Thursday, August 28th were paid a dividend of $0.40 per share. The ex-dividend date was Thursday, August 28th. This represents a $1.60 annualized dividend and a yield of 1.1%. Xylem’s dividend payout ratio is currently 41.13%.
Analyst Ratings Changes
A number of research analysts have issued reports on the stock. Barclays boosted their price objective on shares of Xylem from $165.00 to $172.00 and gave the company an “overweight” rating in a research report on Wednesday, October 29th. Citigroup boosted their price objective on shares of Xylem from $173.00 to $182.00 and gave the company a “buy” rating in a research report on Wednesday, October 29th. Zacks Research raised shares of Xylem from a “hold” rating to a “strong-buy” rating in a research report on Monday, September 22nd. Wall Street Zen raised shares of Xylem from a “hold” rating to a “buy” rating in a research report on Saturday, August 9th. Finally, Mizuho set a $160.00 target price on shares of Xylem in a research report on Wednesday, October 29th. One analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and five have issued a Hold rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $166.20.
Check Out Our Latest Stock Analysis on Xylem
About Xylem
Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.
See Also
- Five stocks we like better than Xylem
- Where Do I Find 52-Week Highs and Lows?
- 3 Cash-Rich Stocks With High Growth Potential Right Now
- Compound Interest and Why It Matters When Investing
- Why Vertical Aerospace Stock Could Double After This Flight Test
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Amazon: Breakout Confirmed—Here’s Where It Could Go Next
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.
